Salveen Richter is a Wall Street analyst working for Goldman Sachs. Salveen has covered 43 stocks with a 41.67% success rate and an average return of 0.47%.

Salveen Richter is a 4.41-star Wall Street Analyst at Goldman Sachs. Salveen Richter's focuses on the Healthcare sector and covers 84 stocks with a 40.86% success rate.

Learn more about the Department of Biomedical Engineering leadership team, including faculty and advisory board members.

Mar 23, 2022 · In the latest episode of Exchanges at Goldman Sachs, Salveen Richter, Lead Analyst for the U.S. Biotechnology Sector in Goldman Sachs Research, explains how new …

Jan 14, 2025 · Analyst Salveen Richter, currently employed at GOLDMAN SACHS, carries an average stock price target met ratio of 65.4% that have a potential upside of 34.24% achieved …

Mar 23, 2022 · Salveen Richter: So gene editing is a versatile tool, and it's capable of making permanent, precise edits to the human genome. So I would think of it as a molecular scissors …

Salveen Richter Analyst Color Get additional color on Salveen Richter's coverage of popular stocks

Nov 12, 2020 · SALVEEN RICHTER: There is the possibility that FDA does not approve a vaccine based on emergency use authorization. But the Expanded Access Program is another path in …

Get the details of Salveen Richter's business profile including email address, phone number, work history and more.